Matches in Wikidata for { <http://www.wikidata.org/entity/Q66064353> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q66064353 description "clinical trial" @default.
- Q66064353 description "ensayu clínicu" @default.
- Q66064353 description "klinisch onderzoek" @default.
- Q66064353 description "клінічне випробування" @default.
- Q66064353 name "Dose-Escalation and Dose-Expansion of RMC-4630 and Cobimetinib in Relapsed/Refractory Solid Tumors" @default.
- Q66064353 name "Dose-Escalation and Dose-Expansion of RMC-4630 and Cobimetinib in Relapsed/Refractory Solid Tumors" @default.
- Q66064353 type Item @default.
- Q66064353 label "Dose-Escalation and Dose-Expansion of RMC-4630 and Cobimetinib in Relapsed/Refractory Solid Tumors" @default.
- Q66064353 label "Dose-Escalation and Dose-Expansion of RMC-4630 and Cobimetinib in Relapsed/Refractory Solid Tumors" @default.
- Q66064353 prefLabel "Dose-Escalation and Dose-Expansion of RMC-4630 and Cobimetinib in Relapsed/Refractory Solid Tumors" @default.
- Q66064353 prefLabel "Dose-Escalation and Dose-Expansion of RMC-4630 and Cobimetinib in Relapsed/Refractory Solid Tumors" @default.
- Q66064353 P1132 Q66064353-21DF22C4-B222-42A8-8121-81B9CCC52472 @default.
- Q66064353 P1476 Q66064353-99E7B72C-D87C-4A00-9D19-D3B44BD1A4E8 @default.
- Q66064353 P17 Q66064353-879126B6-AB77-4941-AE4C-A09FF588BB1F @default.
- Q66064353 P2899 Q66064353-708AC9ED-5448-4C80-84A1-599EBCDBD560 @default.
- Q66064353 P3098 Q66064353-E3689D18-18EF-49D9-A607-C8E3AEAA9897 @default.
- Q66064353 P31 Q66064353-51408E25-1ED8-4E28-ACC0-416908B7BA0F @default.
- Q66064353 P580 Q66064353-A05A8A58-1AFA-4EBC-99F8-7837BB850CFE @default.
- Q66064353 P582 Q66064353-7B1EACC6-DB75-46DB-8B7C-33E5EF131819 @default.
- Q66064353 P6099 Q66064353-29657D52-59B7-40FB-A337-34BFAA3C0BF2 @default.
- Q66064353 P6099 Q66064353-D9E7DC0D-0F04-4114-8DB5-37204EBD8CE2 @default.
- Q66064353 P6153 Q66064353-19274E0E-96AC-4039-9FD3-75D39D3BA7BB @default.
- Q66064353 P6153 Q66064353-490AF3CF-36ED-4D05-83CE-34B283386D51 @default.
- Q66064353 P6153 Q66064353-82649FD2-D8A2-4391-BA33-AF72DBF700E4 @default.
- Q66064353 P6153 Q66064353-9CF04066-5331-44BD-BD9A-BD80690102A0 @default.
- Q66064353 P6153 Q66064353-BE8BCC51-A17F-4E2A-BA38-0FB62FE6007A @default.
- Q66064353 P6153 Q66064353-D87ACCB2-6886-417F-936C-9D4F98742BA6 @default.
- Q66064353 P8363 Q66064353-07B08AA7-4DB8-45C5-8558-A1241D6A56D6 @default.
- Q66064353 P1132 "+144" @default.
- Q66064353 P1476 "A Phase 1b/2, Open-Label, Multicenter Dose-Escalation and Dose-Expansion Study of the Combination of RMC-4630 and Cobimetinib in Adult Participants With Relapsed/Refractory Solid Tumors With Specific Genomic Aberrations" @default.
- Q66064353 P17 Q30 @default.
- Q66064353 P2899 "+18" @default.
- Q66064353 P3098 "NCT03989115" @default.
- Q66064353 P31 Q30612 @default.
- Q66064353 P580 "2019-07-03T00:00:00Z" @default.
- Q66064353 P582 "2022-03-31T00:00:00Z" @default.
- Q66064353 P6099 Q42824440 @default.
- Q66064353 P6099 Q5452194 @default.
- Q66064353 P6153 Q1159198 @default.
- Q66064353 P6153 Q129421 @default.
- Q66064353 P6153 Q309331 @default.
- Q66064353 P6153 Q5476635 @default.
- Q66064353 P6153 Q621043 @default.
- Q66064353 P6153 Q838330 @default.
- Q66064353 P8363 Q78089383 @default.